✦ LIBER ✦

The Next Challenge in Cancer Immunotherapy: Controlling T-Cell Traffic to the Tumor

✍ Scribed by Abastado, J.-P.

Book ID: 111886271
Publisher: American Association for Cancer Research
Year: 2012
Tongue: English
Weight: 179 KB
Volume: 72
Category: Article
ISSN: 0008-5472
DOI: 10.1158/0008-5472.can-11-3538

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Suppressive Tumor Microenvironment:

The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy

✍ Vasievich, Elizabeth A.; Huang, Leaf 📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 1015 KB

Cancer Immunotherapy || T Cell and Antig

Cancer Immunotherapy || T Cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment

✍ Curiel, Tyler J. 📂 Article 📅 2012 🏛 Springer New York ⚖ 249 KB

Pitfalls on the roadmap to γδ T cell-bas

Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies

✍ Ludovic Martinet; Rémy Poupot; Jean-Jacques Fournié 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 622 KB

Immunotherapy of cancer by peptide-based

Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity

✍ Maaike E Ressing; Rienk Offringa; RenéE.M Toes; Ferry Ossendorp; Joan H de Jong; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 887 KB

NK Cells Are Required for Dendritic Cell

NK Cells Are Required for Dendritic Cell-Based Immunotherapy at the Time of Tumor Challenge

✍ Bouwer, A. L.; Saunderson, S. C.; Caldwell, F. J.; Damani, T. T.; Pelham, S. J.; 📂 Article 📅 2014 🏛 American Association of Immunologists 🌐 English ⚖ 623 KB

MHC class II restricted tumor antigens a

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

✍ Suzanne L. Topalian 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 693 KB